Correlation Between Urine UACR and Postoperative Neurocognitive Disorder in Elderly Patients With Non-cardiac Surgery

February 27, 2019 updated by: Han Yuan
This study intends to evaluate the relationship between urinary albumin/creatinine ratio and postoperative neurocognitive impairment in elderly non-cardiac surgery patients. The results of the study are to identify risk factors, screen high-risk populations to improve clinical evidence, early detection and early treatment.And reducing the burden of PNCD on patients and their families, hospitals and public resources.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

400

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Jiangsu
      • Xuzhou, Jiangsu, China
        • Recruiting
        • Department of Anesthesia of the Affiliated Hospital of Xuzhou Medical University
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

We included 400 patients undergoing non-cardiac surgery at the affiliated hospital of Xuzhou Medical University.

Description

Inclusion Criteria:

  • Non-cardiac surgery patients;

    • Age is greater than or equal to 60 years old; ③Han Nationality, mother tongue is chinese;

      ④The MMSE score:Illiteracy is greater than or equal to 17 points, primary school is greater than or equal to 20 points, higher secondary school is more than 24 points;

      ⑤The people signed informed consent.

Exclusion Criteria:

  • The diagnosis of preoperative delirium;

    • The diagnosis Unstable hypertension(Such as:pheochromocytoma or aortic dissection); ③Severe chronic obstructive pulmonary disease or congestive heart failure; ④Severe liver and kidney dysfunction;

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
study group
400 Male and female patients undergoing non-cardiac surgery at the Affiliated Hospital of Xuzhou Medical University [Jiangsu China].We do the neuropsychological tests,MMSE,CCI,CDR,QoR-40,GDS,CAGE Alcoholism Questionnaire,Pure Tone Audiometry,blood albumin、hemoglobin content、ALT、AST、BUN、Cr、serum folic acid、vitamin B12、homocysteine and branched chain amino acid content 1 day before the surgery(baseline); 1 day before the surgery(baseline); Confusion Assessment Method(CAM),NRS once before discharge from PACU and 1、2、3 days after surgery twice a day; QoR-40 1 day after surgery; Neuropsychological tests and MMSE 6±1 days and one month after surgery.
We do the neuropsychological tests, Mini-Mental score examination (MMSE),Charlson Comorbidity Index(CCI),Clinical Dementia Rating(CDR),Quality of Recovery Score - 40 (QoR-40),Geriatric Depression Scale (GDS),CAGE Alcoholism Questionnaire,Pure Tone Audiometry,blood albumin、hemoglobin content、ALT、AST、BUN、Cr、serum folic acid、vitamin B12、homocysteine and branched chain amino acid content 1 day before the surgery(baseline); 1 day before the surgery(baseline); Confusion Assessment Method(CAM),Numerical Rating Scale(NRS)once before discharge from PACU and 1、2、3 days after surgery twice a day; QoR-40 1 day after surgery; Neuropsychological tests and MMSE 6±1 days and one month after surgery.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Confusion Assessment Method(CAM)
Time Frame: before discharge from PACU
Confusion Assessment Method to measure delirium
before discharge from PACU
Confusion Assessment Method(CAM)
Time Frame: morning of the 1st day after surgery
Confusion Assessment Method to measure delirium
morning of the 1st day after surgery
Confusion Assessment Method(CAM)
Time Frame: afternoon of the 1st day after surgery
Confusion Assessment Method to measure delirium
afternoon of the 1st day after surgery
Confusion Assessment Method(CAM)
Time Frame: morning of the 2st day after surgery
Confusion Assessment Method to measure delirium
morning of the 2st day after surgery
Confusion Assessment Method(CAM)
Time Frame: afternoon of the 2st day after surgery
Confusion Assessment Method to measure delirium
afternoon of the 2st day after surgery
Confusion Assessment Method(CAM)
Time Frame: morning of the 3st day after surgery
Confusion Assessment Method to measure delirium
morning of the 3st day after surgery
Confusion Assessment Method(CAM)
Time Frame: afternoon of the 3st day after surgery
Confusion Assessment Method to measure delirium
afternoon of the 3st day after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of Recovery Score - 40 (QoR-40)
Time Frame: 1 day before surgery(baseline)
Quality of recovery will be evaluated by Quality of Recovery 40 (QoR40),which assesses five dimensions of recovery (physical comfort,emotional state, physical independence , physiological support and pain ). Each item is rated on a five-point Likert scale: none of the time, some of the time, usually, most of the time, and all the time. The total score on the QoR40 ranges from 40 (poorest quality of recovery) to 200 (best quality of recovery).
1 day before surgery(baseline)
Quality of Recovery Score - 40 (QoR-40)
Time Frame: 1 day after surgery
Quality of recovery will be evaluated by Quality of Recovery 40 (QoR40),which assesses five dimensions of recovery (physical comfort,emotional state, physical independence , physiological support and pain ). Each item is rated on a five-point Likert scale: none of the time, some of the time, usually, most of the time, and all the time. The total score on the QoR40 ranges from 40 (poorest quality of recovery) to 200 (best quality of recovery).
1 day after surgery
Numerical Rating Scale(NRS)
Time Frame: before discharge from PACU
Evaluate the severity using numerical rating scale(NRS), where zero mean no pain and 10 the worst imaginable pain.
before discharge from PACU
Numerical Rating Scale(NRS)
Time Frame: morning of the 1st day after surgery
Evaluate the severity using numerical rating scale(NRS), where zero mean no pain and 10 the worst imaginable pain.
morning of the 1st day after surgery
Numerical Rating Scale(NRS)
Time Frame: afternoon of the 1st day after surgery
Evaluate the severity using numerical rating scale(NRS), where zero mean no pain and 10 the worst imaginable pain.
afternoon of the 1st day after surgery
Numerical Rating Scale(NRS)
Time Frame: morning of the 2st day after surgery
Evaluate the severity using numerical rating scale(NRS), where zero mean no pain and 10 the worst imaginable pain.
morning of the 2st day after surgery
Numerical Rating Scale(NRS)
Time Frame: afternoon of the 2st day after surgery
Evaluate the severity using numerical rating scale(NRS), where zero mean no pain and 10 the worst imaginable pain.
afternoon of the 2st day after surgery
Numerical Rating Scale(NRS)
Time Frame: morning of the 3st day after surgery
Evaluate the severity using numerical rating scale(NRS), where zero mean no pain and 10 the worst imaginable pain.
morning of the 3st day after surgery
Numerical Rating Scale(NRS)
Time Frame: afternoon of the 3st day after surgery
Evaluate the severity using numerical rating scale(NRS), where zero mean no pain and 10 the worst imaginable pain.
afternoon of the 3st day after surgery
Mini-Mental score examination (MMSE)
Time Frame: 1 day before surgery(baseline)
Mini-Mental score examination [MMSE] used for screening of dementia
1 day before surgery(baseline)
Mini-Mental score examination (MMSE) and Neuropsychological tests
Time Frame: 6±1 days after surgery
Mini-Mental score examination (MMSE) and Neuropsychological tests to measure cognitive function, including the Trail
6±1 days after surgery
Mini-Mental score examination (MMSE) and Neuropsychological tests
Time Frame: one month after surgery
Mini-Mental score examination (MMSE) and Neuropsychological tests to measure cognitive function, including the Trail
one month after surgery
serum folic acid levels
Time Frame: 1 day before surgery(baseline)
Record preoperative serum folic acid levels
1 day before surgery(baseline)
serum vitamin B12 levels
Time Frame: 1 day before surgery(baseline)
Record preoperative serum vitamin B12 levels
1 day before surgery(baseline)
serum homocysteine content
Time Frame: 1 day before surgery(baseline)
Record preoperative serum homocysteine content
1 day before surgery(baseline)
serum branched chain amino acid content
Time Frame: 1 day before surgery(baseline)
Record preoperative serum branched chain amino acid content
1 day before surgery(baseline)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
blood Albumin levels
Time Frame: before surgery(baseline)
Record preoperative blood Albumin levels
before surgery(baseline)
blood Hemoglobin content
Time Frame: before surgery(baseline)
Record preoperative blood Hemoglobin content
before surgery(baseline)
blood Alanine aminotransferase (ALT) levels
Time Frame: before surgery(baseline)
Record preoperative blood Alanine aminotransferase (ALT) levels
before surgery(baseline)
blood Aspartate aminotransferase (AST)levels
Time Frame: before surgery(baseline)
Record preoperative blood Aspartate aminotransferase (AST)levels
before surgery(baseline)
Blood urea nitrogen(BUN) levels
Time Frame: before surgery(baseline)
Record preoperative Blood urea nitrogen(BUN) levels
before surgery(baseline)
Blood creatinine(Cr) levels
Time Frame: before surgery(baseline)
Record preoperative Blood creatinine(Cr) levels
before surgery(baseline)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2019

Primary Completion (Anticipated)

December 30, 2019

Study Completion (Anticipated)

May 30, 2020

Study Registration Dates

First Submitted

February 22, 2019

First Submitted That Met QC Criteria

February 27, 2019

First Posted (Actual)

March 4, 2019

Study Record Updates

Last Update Posted (Actual)

March 4, 2019

Last Update Submitted That Met QC Criteria

February 27, 2019

Last Verified

February 1, 2019

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Delirium

Clinical Trials on Neuropsychological tests

3
Subscribe